Home Cart 0 Sign in  
X

[ CAS No. 59247-47-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 59247-47-1
Chemical Structure| 59247-47-1
Chemical Structure| 59247-47-1
Structure of 59247-47-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 59247-47-1 ]

Related Doc. of [ 59247-47-1 ]

Alternatived Products of [ 59247-47-1 ]

Product Details of [ 59247-47-1 ]

CAS No. :59247-47-1 MDL No. :MFCD00093266
Formula : C11H13BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :BFJJYXUCGYOXDM-UHFFFAOYSA-N
M.W : 257.12 Pubchem ID :11334366
Synonyms :

Calculated chemistry of [ 59247-47-1 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.36
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 59.88
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.99
Log Po/w (XLOGP3) : 3.45
Log Po/w (WLOGP) : 3.4
Log Po/w (MLOGP) : 3.53
Log Po/w (SILICOS-IT) : 3.11
Consensus Log Po/w : 3.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.73
Solubility : 0.0482 mg/ml ; 0.000188 mol/l
Class : Soluble
Log S (Ali) : -3.68
Solubility : 0.0533 mg/ml ; 0.000207 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.15
Solubility : 0.0181 mg/ml ; 0.0000703 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.6

Safety of [ 59247-47-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 59247-47-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 59247-47-1 ]
  • Downstream synthetic route of [ 59247-47-1 ]

[ 59247-47-1 ] Synthesis Path-Upstream   1~22

  • 1
  • [ 865-47-4 ]
  • [ 586-75-4 ]
  • [ 59247-47-1 ]
YieldReaction ConditionsOperation in experiment
95% at -78 - 20℃; for 2 h; tert-Butyl 4-bromobenzoate. To a solution of 4-bromobenzoyl chloride (25.08 g, 114 mmol) in THF (120 mL) at -78°C was added potassium toert-butoxide (120 mL, 1 M in THF, 120 mmol). The reaction mixture was warmed from -78°C to room temperature over 2 h, and diluted with diethyl ether. The organic phase was washed with saturated NaHCψ3 (2 x), brine (1 x), dried over MgSO4, filtered, and EPO <DP n="74"/>concentrated. Purification by flash column chromatography on silica gel (5percent ethyl acetate in hexanes) gave tert-butyl 4-bromobenzoate (27.96 g, 95percent) as a colorless oil: 1H NMR (600 MHz, CDCl3) δ 7.84 (d, J = 8.5 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 1.59 (s, 9H); ESIMS calcd 257.0 (M+ + H), found 257.1 (M+ + H).
Reference: [1] RSC Advances, 2016, vol. 6, # 22, p. 18165 - 18177
[2] Journal of Organic Chemistry, 2000, vol. 65, # 17, p. 5428 - 5430
[3] Patent: WO2007/2248, 2007, A2, . Location in patent: Page/Page column 72-73
[4] Organic Process Research and Development, 2012, vol. 16, # 11, p. 1832 - 1845
[5] Journal of the American Chemical Society, 2016, vol. 138, # 32, p. 10293 - 10298
[6] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 16, p. 4619 - 4624
[7] Patent: WO2010/80971, 2010, A1, . Location in patent: Page/Page column 14
[8] Journal of Materials Chemistry, 2012, vol. 22, # 15, p. 7366 - 7379
[9] Organic Letters, 2012, vol. 14, # 18, p. 4726 - 4729,4
  • 2
  • [ 586-76-5 ]
  • [ 24424-99-5 ]
  • [ 59247-47-1 ]
YieldReaction ConditionsOperation in experiment
62% With dmap In <i>tert</i>-butyl alcohol at 20℃; for 12 h; Tert-butyl 4-bromobenzoate. To a solution of 4-dimethylamiopryidine (1.5 g, 12.5 mmol) in tert-butanol (20 mL) were added 4-bromobenzoic acid (5 g, 25 mmol) and di-tert-butyl dicarbonate (10.95 g, 0.05 mol). The mixture was stirred at 20°C for 12 hours. The resultant mixture was concentrated in vacuo to give a residue and the residue was purified by column chromatography (silica gel, petroleum ether/ethyl acetate = 30: 1) to give tert-butyl 4- bromobenzoate (4 g, 62percent>).
62% With dmap In <i>tert</i>-butyl alcohol at 20℃; for 12 h; To a solution of 4-dimethylamiopryidine (1.5 g, 12.5 mmol) in tert-butanol (20 mL) were added 4-bromobenzoic acid (5 g, 25 mmol) and di-tert-butyl dicarbonate (10.95 g, 0.05 mol). The mixture was stirred at 20° C. for 12 hours. The resultant mixture was concentrated in vacuo to give a residue and the residue was purified by column chromatography (silica gel, petroleum ether/ethyl acetate=30:1) to give tert-butyl 4-bromobenzoate (4 g, 62percent).
21% With dmap In <i>tert</i>-butyl alcohol at 50℃; To a 1000-mL round-bottom flask was added 4-bromobenzoic acid 52a (20 g, 99.495 mmol, 1.0 equiv.), tert-butano (200 mL), 4-dimethylaminopyridine (1.22 g, 9.99 mmol, 0.10equiv.), and Boc20 (32 7 g, 149.83 mmoL 150 equiv) and the resulting mixture ·was stirredat 50 °C ovemight. The mixture was diluted vvith 200 mL of H20 and extracted with ethylacetate (300 mL x 2). "fl1e combined organic extracts were washed with brine (300 mL x 2),dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. Thel 0 crude product was purified by Flash-Prep-HPLC using the following conditions: Column,silica gel; mobile phase, PE:EA = 100:0 increasing to 90:10 over 5 min; Detector, UV 254nm, to provide 5.43 g (21 percent) oftert-butyl4-bromobenzoate 52b as a colorless oil.
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 14, p. 3874 - 3877[2] Angew. Chem., 2013, p. 3966 - 3969
[3] Patent: WO2013/75083, 2013, A1, . Location in patent: Paragraph 00260; 00261; 00431; 00432
[4] Patent: US9206128, 2015, B2, . Location in patent: Page/Page column 137; 138; 202; 203
[5] Patent: WO2018/39386, 2018, A1, . Location in patent: Page/Page column 216; 217
  • 3
  • [ 586-76-5 ]
  • [ 75-65-0 ]
  • [ 59247-47-1 ]
YieldReaction ConditionsOperation in experiment
62% at 20℃; for 12 h; tert-Butyl 4-bromobenzoate. To a solution of 4-dimethylaminopyridine (1.5 g, 12.5 mmol) in tert-butanol(20 mL) were added 4-bromobenzoic acid (5.0 g, 25 mmol) and di-tert-butyldicarbonate (10.95 g, 50 mmol). The mixture was stirred at 20 °C for 12 h. The resultant mixture was concentrated in vacuo and the residue was purified by silica gel chromatography (petroleumether/ethyl acetate = 30:1) to provide tert-butyl 4-bromobenzoate (4.0 g, 62percent).
55% With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In chloroform at 20℃; for 18 h; To a solution of 4-bromobenzoic acid (lOg, 49.7 mmol) in Chlorofonri (150 ml), 2- methylpropan-2-ol (18.44g, 249 mmol), EDC.HC1 (23.84g, 124 mmol), followed by DMAP (15.19g, 124 mmol) was added and stined for 18h at room temperature. After completion of reaction as indicated by TLC, the mixture was poured into water and extracted with DCM. The organic layer was collected and dried over sodium sulphate,finally evaporated and purified by column chromatography (7g, 55 percent). 1H NMR (400MHz, Chloroform-d) 7.87 (d, 2H), 7.57 (d, 2H), 1.61 (s, 9H).
49 g With dmap; diisopropyl-carbodiimide In dichloromethane at 35℃; for 5 h; In dichloromethane, 4-bromobenzoic acid (50 g), tert-butyl alcohol (20.3 g), and dimethylaminopyridine (12.2 g) were dissolved. The resulting solution was added drop- wise to diisopropylcarbodiimide (DIC, 37.7 g) at 35° C. The resulting mixture was stirred for 5 hours. Subsequently, the reaction liquid was filtered, and the filtrate was concentrated. The resulting solid was purified by column chromatography. Hereby, the compound M- 1 (49 g) was prepared
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3644 - 3649
[2] Patent: WO2017/37682, 2017, A1, . Location in patent: Page/Page column 91
[3] Patent: US2017/260150, 2017, A1, . Location in patent: Paragraph 0169; 0170
  • 4
  • [ 873-75-6 ]
  • [ 75-65-0 ]
  • [ 59247-47-1 ]
YieldReaction ConditionsOperation in experiment
87% With 1H-imidazole; tert.-butylhydroperoxide; tetra-(n-butyl)ammonium iodide In water at 80℃; for 7 h; Green chemistry General procedure: To a mixture of benzyl alcohol (108 mg, 1.0 mmol) and TBHP(180 mg, 2.0 mmol) in water (3 ml), the catalyst TBAI (73.8 mg,0.2 mmol), imidazole (136 mg, 2.0 mmol), and MeOH (2 ml)were added, and the mixture was stirred at 80 °C for 8 h. Theprogress of the reaction was monitored by TLC. After completionof reaction, the reaction mixture was cooled to room temperature.Then MeOH was distilled out, and the organic productwas extracted with ethyl acetate (3 × 10 ml), repeatedly washedwith distilled water (4 × 5 ml) to remove the unreacted TBHP,dried with anhydrous sodium sulfate, and the solvent was evaporatedunder reduced pressure to afford methyl benzoate (112mg, yield 82percent).
Reference: [1] Synlett, 2018, vol. 29, # 16, p. 2208 - 2212
  • 5
  • [ 1450732-52-1 ]
  • [ 59247-47-1 ]
YieldReaction ConditionsOperation in experiment
51% With 3-chloro-benzenecarboperoxoic acid; copper(ll) bromide In 1,4-dioxane at 70℃; for 3 h; General procedure: To a solution of m-CPBA(1.2 mmol) and CuBr2 (0.1 mmol) in dry 1,4-dioxane (10 mL) was addeddropwise a solution of compound 1 (1mmol). The reaction mixture was stirred at the designated temperature until theTLC indicated the consumption of the starting martial compound 1. After the reaction was completed,the reaction mixture was allowed to cool to room temperature, and EtOAc (20 mL)was added. The resulting mixture was washed with saturated aqueous Na2S2O3(10mL) and saturated aqueousNa2CO3 (10 mL). The organic layer was dried overanhydrous Na2SO4, filtered, and removed under reducedpressure. The residue was purified by flash column chromatography on silica gelto give the desired products.
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 31, p. 4634 - 4637
[2] Journal of Organic Chemistry, 2013, vol. 78, # 17, p. 8705 - 8711
  • 6
  • [ 586-75-4 ]
  • [ 75-65-0 ]
  • [ 59247-47-1 ]
YieldReaction ConditionsOperation in experiment
70% With pyridine In dichloromethane A.
tert.-Butyl 4-Bromobenzoate
To a mixture of 5.5 g of dry tert.-butanol and 7.08 g of dry pyridine is added a solution of 9.79 g of 4-bromobenzoyl chloride in 20 ml of anhydrous methylene chloride.
The mixture is stirred under nitrogen for 2 days.
The reaction mixture is then diluted with methylene chloride, and the organic solution extracted with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure.
The residual oil is distilled under reduced pressure to give 8.9 g (70percent) of tert.-butyl 4-bromobenzoate as a colorless oil: b.p. 91°-92° C./1.2 mm; NMR (CDCl3, 80 MHz) delta 1.59 (s, 9H), 7.53 (d, 2H, J=8.7 Hz); IR (neat) 2970, 1710, 1585, 1475, 1390, 1290, 1160, 1110, 1070, 845 and 745 cm-1.
Anal. Calcd. for C11 H13 BrO2: C, 51.38; H, 5.09; Br, 31.08. Found: C, 51.41; H, 5.36; Br, 30.38.
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 1, p. 35 - 38
[2] Journal of Organic Chemistry, 1989, vol. 54, # 15, p. 3618 - 3624
[3] Journal of Medicinal Chemistry, 1991, vol. 34, # 8, p. 2570 - 2579
[4] Patent: US4818819, 1989, A,
  • 7
  • [ 201230-82-2 ]
  • [ 106-40-1 ]
  • [ 75-65-0 ]
  • [ 59247-47-1 ]
Reference: [1] Angewandte Chemie - International Edition, 2015, vol. 54, # 7, p. 2270 - 2274[2] Angew. Chem., 2014, vol. 127, # 7, p. 2298 - 2302,5
[3] Organic and Biomolecular Chemistry, 2017, vol. 15, # 32, p. 6715 - 6719
  • 8
  • [ 106-37-6 ]
  • [ 24424-99-5 ]
  • [ 59247-47-1 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 12, p. 2034 - 2037
[2] Organic Syntheses, 2012, vol. 89, p. 460 - 470
  • 9
  • [ 110-05-4 ]
  • [ 1122-91-4 ]
  • [ 59247-47-1 ]
Reference: [1] RSC Advances, 2013, vol. 3, # 33, p. 13668 - 13670
  • 10
  • [ 586-76-5 ]
  • [ 865-47-4 ]
  • [ 59247-47-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 21, p. 8564 - 8572
  • 11
  • [ 75-91-2 ]
  • [ 16532-79-9 ]
  • [ 59247-47-1 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 104, p. 102023 - 102027
  • 12
  • [ 619-42-1 ]
  • [ 865-48-5 ]
  • [ 59247-47-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 22, p. 4705 - 4713
  • 13
  • [ 586-76-5 ]
  • [ 59247-47-1 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 35, p. 14042 - 14053
[2] Journal of Materials Chemistry, 2012, vol. 22, # 15, p. 7366 - 7379
[3] Journal of Organic Chemistry, 2013, vol. 78, # 17, p. 8705 - 8711
  • 14
  • [ 75-91-2 ]
  • [ 1122-91-4 ]
  • [ 59247-47-1 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 36, p. 4751 - 4754
  • 15
  • [ 586-75-4 ]
  • [ 59247-47-1 ]
Reference: [1] Journal of Organic Chemistry, 2013, vol. 78, # 17, p. 8705 - 8711
  • 16
  • [ 82892-00-0 ]
  • [ 75-65-0 ]
  • [ 59247-47-1 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 35, p. 14042 - 14053
  • 17
  • [ 59247-47-1 ]
  • [ 10602-00-3 ]
Reference: [1] Journal of Organic Chemistry, 1989, vol. 54, # 15, p. 3618 - 3624
  • 18
  • [ 59247-47-1 ]
  • [ 18144-47-3 ]
  • [ 150-13-0 ]
Reference: [1] Organic Letters, 2002, vol. 4, # 26, p. 4689 - 4692
  • 19
  • [ 59247-47-1 ]
  • [ 68-12-2 ]
  • [ 65874-27-3 ]
Reference: [1] Synthetic Communications, 1999, vol. 29, # 19, p. 3401 - 3407
[2] Synthetic Communications, 1999, vol. 29, # 19, p. 3401 - 3407
  • 20
  • [ 59247-47-1 ]
  • [ 1066-54-2 ]
  • [ 111291-97-5 ]
Reference: [1] Patent: US4818819, 1989, A,
  • 21
  • [ 59247-47-1 ]
  • [ 111291-97-5 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 1, p. 35 - 38
[2] Journal of Organic Chemistry, 1989, vol. 54, # 15, p. 3618 - 3624
  • 22
  • [ 59247-47-1 ]
  • [ 850568-54-6 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 32, p. 10293 - 10298
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 59247-47-1 ]

Aryls

Chemical Structure| 5798-75-4

[ 5798-75-4 ]

Ethyl 4-bromobenzoate

Similarity: 0.94

Chemical Structure| 127437-29-0

[ 127437-29-0 ]

Diethyl 5-bromoisophthalate

Similarity: 0.92

Chemical Structure| 55666-42-7

[ 55666-42-7 ]

tert-Butyl 2-bromobenzoate

Similarity: 0.91

Chemical Structure| 619-42-1

[ 619-42-1 ]

Methyl 4-bromobenzoate

Similarity: 0.90

Chemical Structure| 51329-15-8

[ 51329-15-8 ]

Methyl 3,5-dibromobenzoate

Similarity: 0.89

Bromides

Chemical Structure| 5798-75-4

[ 5798-75-4 ]

Ethyl 4-bromobenzoate

Similarity: 0.94

Chemical Structure| 127437-29-0

[ 127437-29-0 ]

Diethyl 5-bromoisophthalate

Similarity: 0.92

Chemical Structure| 55666-42-7

[ 55666-42-7 ]

tert-Butyl 2-bromobenzoate

Similarity: 0.91

Chemical Structure| 64169-34-2

[ 64169-34-2 ]

5-Bromoisobenzofuran-1(3H)-one

Similarity: 0.91

Chemical Structure| 19477-73-7

[ 19477-73-7 ]

6-Bromoisobenzofuran-1(3H)-one

Similarity: 0.91

Esters

Chemical Structure| 5798-75-4

[ 5798-75-4 ]

Ethyl 4-bromobenzoate

Similarity: 0.94

Chemical Structure| 127437-29-0

[ 127437-29-0 ]

Diethyl 5-bromoisophthalate

Similarity: 0.92

Chemical Structure| 55666-42-7

[ 55666-42-7 ]

tert-Butyl 2-bromobenzoate

Similarity: 0.91

Chemical Structure| 64169-34-2

[ 64169-34-2 ]

5-Bromoisobenzofuran-1(3H)-one

Similarity: 0.91

Chemical Structure| 19477-73-7

[ 19477-73-7 ]

6-Bromoisobenzofuran-1(3H)-one

Similarity: 0.91